Cite
Combining alpha radiation-based brachytherapy with immunomodulators promotes complete tumor regression in mice via tumor-specific long-term immune response.
MLA
Domankevich, Vered, et al. “Combining Alpha Radiation-Based Brachytherapy with Immunomodulators Promotes Complete Tumor Regression in Mice via Tumor-Specific Long-Term Immune Response.” Cancer Immunology, Immunotherapy, vol. 68, no. 12, Dec. 2019, pp. 1949–58. EBSCOhost, https://doi.org/10.1007/s00262-019-02418-5.
APA
Domankevich, V., Cohen, A., Efrati, M., Schmidt, M., Rammensee, H.-G., Nair, S. S., Tewari, A., Kelson, I., & Keisari, Y. (2019). Combining alpha radiation-based brachytherapy with immunomodulators promotes complete tumor regression in mice via tumor-specific long-term immune response. Cancer Immunology, Immunotherapy, 68(12), 1949–1958. https://doi.org/10.1007/s00262-019-02418-5
Chicago
Domankevich, Vered, Adi Cohen, Margalit Efrati, Michael Schmidt, Hans-Georg Rammensee, Sujit S. Nair, Ashutosh Tewari, Itzhak Kelson, and Yona Keisari. 2019. “Combining Alpha Radiation-Based Brachytherapy with Immunomodulators Promotes Complete Tumor Regression in Mice via Tumor-Specific Long-Term Immune Response.” Cancer Immunology, Immunotherapy 68 (12): 1949–58. doi:10.1007/s00262-019-02418-5.